Article Information
History
- November 16, 2021.
Article Versions
- Version 1 (September 22, 2021 - 11:20).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Veerle P. W. M. Wijtvliet1,2,*,
- Kevin K. Ariën3,4,
- Steven Abrams5,6,
- Marie M. Couttenye1,2,
- Fabienne Mestrez7,
- Joachim Mariën3,8,
- Benedicte Y. De Winter1,
- Pierre Van Damme9,
- Lissa Pipeleers10,
- Karl Martin Wissing10,
- Daniel Abramowicz1,2 and
- Kristien J. Ledeganck1
- 1Laboratory of Experimental Medicine and Pediatrics and member of the Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium
- 2Department of Nephrology and Hypertension, Antwerp University Hospital, Edegem, Belgium
- 3Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium
- 4Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
- 5Department of Epidemiology and Social Medicine, Global Health Institute, University of Antwerp, Antwerp, Belgium
- 6I-BioStat, Data Science Institute, Hasselt University, Diepenbeek, Belgium
- 7Department of Nephrology-Dialysis, University Hospital (CHU) Ambroise Paré, Mons, Belgium
- 8Evolutionary Ecology Group, Department of Biology, University of Antwerp, Antwerp, Belgium
- 9Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
- 10Department of Nephrology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium
- ↵*Corresponding author: Veerle Wijtvliet, MD. Antwerp University Hospital, Department of Nephrology and Hypertension. Drie Eikenstraat 655, 2650 Edegem, Belgium., Electronic address: veerle.wijtvliet{at}uantwerpen.be, Phone number: +32 3 265 2591.
Posted November 16, 2021.
mRNA-1273 vaccine (Moderna): a better option than BNT162b2 (Pfizer) in kidney transplant recipients and dialysis patients?
